Trubion Pharmaceuticals, Inc Sample Contracts

to THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT Dated 08 January 2004
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
AutoNDA by SimpleDocs
AMENDMENT NO. 1
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
RECITALS
Loan and Security Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • California
AMENDMENT NO. 1 TO
Investor Rights Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc
BETWEEN
Services Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and between
Collaboration and License Agreement • October 5th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT Dated 08 January 2004
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
EXHIBIT 4.2 TRUBION PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Rights Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc • Delaware
MANUFACTURING
Manufacturing Services Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
RECITALS
Common Stock Purchase Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc • Delaware
BETWEEN
Quality Agreement • October 5th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations
Employment Agreement
Employment Agreement • March 15th, 2010 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Washington

This Employment Agreement (the “Agreement”) is entered into by and between John A. Bencich (the “Executive”) and Trubion Pharmaceuticals, Inc., a Delaware corporation (the “Company”) as of November 16, 2009 (the “Effective Date”).

MASTER SECURITY AGREEMENT NO. 3081027 Dated as of JUNE 18, 2003 ("AGREEMENT")
Master Security Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc • Virginia
LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • July 29th, 2008 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of the Effective Date between SILICON VALLEY BANK, a California corporation and with a loan production office located at 901 Fifth Avenue, Suite 3900, Seattle, Washington 98164 (“Bank”), and TRUBION PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:

TRUBION PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreement • August 13th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

This Indemnification Agreement (“Agreement”) is made as of this ___day of ___, by and between Trubion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ___(“Indemnitee”).

RELATING TO
Portsmouth Quality Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations
CONTINGENT VALUE RIGHTS AGREEMENT
Contingent Value Rights Agreement • August 13th, 2010 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York

THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of August 12, 2010 (this “Agreement”), is entered into by and among Emergent BioSolutions Inc., a Delaware corporation (“Parent”), Trubion Pharmaceuticals, Inc., a Delaware corporation (“Company”), and Mellon Investor Services LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT
And Manufacturing Services Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc
AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER BY AND AMONG EMERGENT BIOSOLUTIONS INC., 30333 INC. AND TRUBION PHARMACEUTICALS, INC. Dated as of August 12, 2010
Agreement and Plan of Merger and Reorganization • August 13th, 2010 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware

(together with all annexes, letters, schedules and exhibits hereto, this “Agreement”), dated as of August 12, 2010, is by and among Emergent BioSolutions Inc. a Delaware corporation (“Parent”), 35406 LLC, a Delaware limited liability company and wholly owned direct subsidiary of Parent (sometimes referred to herein as the “LLC” or the “Final Surviving Entity”), 30333 Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (sometimes referred to herein as “Merger Sub”), and Trubion Pharmaceuticals, Inc. a Delaware corporation (the “Company” or the “Interim Surviving Corporation”).

EXHIBIT 10.9 December 8, 2004 Mr. Hans van Houte VP Finance and Administration TRUBION PHARMACEUTICALS, INC. 2401 Fourth Avenue, Suite 1050 Seattle, Washington 98121 Dear Hans: Please refer to your lease dated April 28, 2003 and all subsequent addenda...
Trubion Pharmaceuticals, Inc • June 2nd, 2006

Please refer to your lease dated April 28, 2003 and all subsequent addenda thereto (the "Lease") for the space you occupy within the Fourth and Battery Building. This letter (this "Amendment") shall constitute an amendment to that Lease. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Lease.

MANUFACTURING
Manufacturing Services Agreement • August 18th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
RECITALS
Independent Contractor Agreement • July 18th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • Delaware
RECITALS
Investment Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc
THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT Dated 08 January 2004
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
TO THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT DATED 08 JANUARY 2004
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
Amendment No. 1 to Agreement and Plan of Merger
Agreement and Plan of Merger • September 30th, 2010 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations
to THE DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT Dated 08 January 2004
Trubion Pharmaceuticals, Inc • September 22nd, 2006 • Pharmaceutical preparations
QUALITY AGREEMENT for TRU-016 between TRUBION PHARMACEUTICALS, INC. and LONZA SALES AG
Quality Agreement • November 5th, 2009 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York

This Quality Agreement (“Quality Agreement”) is dated effective as of November ___, 2008, and it defines the roles and responsibilities for the quality operations between TRUBION PHARMACEUTICALS, INC. (“Trubion” and “Customer”) and LONZA SALES AG (“Lonza”) with respect to the manufacture of Customer’s product commonly referred to as TRU-016 under that certain Manufacturing Services Agreement dated as of November 21, 2005, between Trubion and Lonza Biologics, Inc. (“Biologics”) (as amended and novated, the “MSA”). Concurrently herewith, the parties are also entering into an amendment to manufacturing services in order to amend the MSA as appropriate for the manufacture of TRU-016 (the “Amendment”). Lonza is the successor in interest to Biologics under the MSA pursuant to that certain Novation Agreement effective as of January 1, 2007, among Trubion, Lonza and Biologics.

Time is Money Join Law Insider Premium to draft better contracts faster.